Tuesday, November 16, 2010

Artificial Heart Implanted Successfully

Cardiac surgeons of the Omsk regional hospital have successfully implanted first two artificial hearts to patients with serious heart failure.

Two patients, a 35-year-old man and a 58-year-old woman, now have artificial hearts made of titanium and silicone. Medics say both patients are feeling well.

The patients will require about three weeks to fully recover, before they return to usual active lifestyle. An artificial heat weighs 284 grams. To date similar surgery, involving long-term assisted blood circulation, has been performed on 23 patients in Russia.

The technique of assisted blood circulation has been developed in Germany, and Russian surgeons have mastered it up.

Via : russia-ic

Monday, October 25, 2010

New Vitamin E Treatment for Prostate Cancer

Queensland University of Technology (QUT) prostate cancer researchers have found that a new vitamin E treatment could significantly reduce tumour regrowth.

Dr Patrick Ling, whose research will be a centrepiece of the new 354 million dollars Translational Research Institute (TRI) when it opens in Brisbane, is leading a team of researchers who have identified a particular constituent of vitamin E, known as tocotrienol (T3), which can inhibit the growth of prostate tumours.

Construction of TRI has officially began (October 19) at the Princess Alexandra Hospital.

Dr Ling said existing chemotherapy and hormonal therapy treatment of prostate cancer was insufficient because it failed to kill off the prostate cancer stem cells (CSCs), which were believed to be responsible for the regrowth of tumours.

However, the research team have discovered a particular form of T3, called gamma-tocotrienol (?-T3), can successfully kill off the prostate cancer CSCs.

"Currently there is no effective treatment for metastatic prostate cancer, because it grows back after conventional therapies in more than 70 per cent of cases," he said.

"But with ?-T3, QUT researchers have found a better way to treat prostate cancer, which has the potential to inhibit recurrence of the disease."

Dr Ling said in animal trials, ?-T3 completely inhibited tumour formation in more than 70 per cent of the mice implanted with prostate cancer cells and fed the vitamin E constituent in water. In the remaining cases, tumour regrowth was considerably reduced, while tumours reformed in 100 per cent of the control group.

Dr Ling said while not all vitamin E preparations had the active constituent, natural vitamin E obtained from palm oil was rich in ?-T3.

The findings have been published in the International Journal of Cancer.

Via : medindia

Allergy, asthma inflammation can be cured by black rice: Study

Black rice has proved to be extremely beneficial for people suffering from inflammation that result from allergy and asthma. Black rice is the staple food for one third of the population. The study appears in ACS' bi-weekly Journal of Agricultural and Food Chemistry. It is also known that black rice is the cancer fighting superfood.

The Journal of Agriculture and Food Chemistry has published an article on October 20 which details upon the findings of how black rice can cure inflammation for allergy and asthma. Experiments in cell culture reveal that black rice bran curbs the release of histamine, which is responsible for inflammation.

Bran is the outer husk of the grain, which, is removed completely during the processing of brown rice to produce the known and popular white rice. Mendel Friedman and colleagues injected the extract into the mice; it reduced skin inflammation by about 32 percent compared to control animals and also decreased production of certain substances known to promote inflammation.

When the mice were fed with ten percent black rice bran diet, it reduces swelling associated with allergic contact dermatitis. This is common type of skin irritation and can occur to anyone anytime. However, brown rice bran did not have such effects. The article also notes that the experiment “further demonstrate the potential value of black rice bran as an anti-inflammatory and anti-allergic food ingredient and possibly also as a therapeutic agent for the treatment and prevention of diseases associated with chronic inflammation.”

Black rice is high in nutritional value and is also rich in iron. It is also high in fiber content and has a nutty taste. Black rice is also known as “forbidden rice” in China since originally it was considered the emperor’s rice and common men were not supposed to consume it. According to a study presented at the 240th National Meeting of the American Chemical Society (ACS), "one spoonful of black rice bran contains more anthocyanin antioxidants than a spoonful of blueberries and better yet, black rice offers more fiber and vitamin E antioxidants, but less sugar.”

Via : infocera

Woman Suffering Asthma Attack Denied Inhaler at Pharmacy


A New Jersey woman suffering an asthma attack was denied an inhaler at a pharmacy because she was $1.99 short, MyFoxNY.com reported.

Katherine O’Connor and her boyfriend were walking home from McDonald’s in Garwood, N.J., Thursday morning when she had the asthma attack, but she did not have her inhaler with her. She went to a nearby CVS, hoping to get a refill on her inhaler prescription.

But, O’Connor was denied the refill because she did not have enough money to pay for the prescription. The medicine cost just over $21, and the couple was short $1.99.

"I had exactly a $20 bill. It came to $21 and change," said O’Connor’s boyfriend, Jack Brown. "I offered him my cell phone, my wallet. I said, ‘I live right around the corner.’ I come in here all the time."

Brown begged the pharmacist to give his girlfriend the inhaler, as she was on the floor wheezing, but the pharmacist would not give in, he said.

Brown called a friend who is a paramedic, who showed up immediately and treated O’Connor.
When questioned about the incident, a store manager had “no comment.”

“The well-being of our customers is our highest priority and we are looking into this matter,” said a statement from CVS corporate offices.

Via : foxnews

Volatile Organic Compounds May Worsen Allergies and Asthma

Children who sleep in bedrooms containing fumes from water-based paints and solvents are two to four times more likely to suffer allergies or asthma, according to a new scientific study.

Scientists measured the compounds – propylene glycol and glycol ethers, known as PGEs – in the bedroom air of 400 toddlers and preschoolers, and discovered that the children who breathed them had substantially higher rates of asthma, stuffy noses and eczema.

It is the first human study to link harmful effects of these chemicals to common exposures in households, and it suggests that they might exacerbate or even cause allergic disorders and asthma, according to the team of scientists from Harvard University and Sweden’s Kalstad University.

“Apparent risks of PGEs at such low concentrations at home raise concerns for the vulnerability of infants and young children,” according to the report, published Monday in the journal of the Public Library of Science, PLoS ONE.

The aim of the study was to investigate the health effects of chemicals called volatile organic compounds that are widely used inside homes. The result: Of the hundreds of compounds tested in eight different categories, only one group -- the PGEs - was associated with the children’s allergies and asthma.

That discovery is particularly surprising, since PGEs are widely used in water-based paints and varnishes, as well as in cleaning fluids such as glass cleaners. They are considered healthier substitutes because they have low volatility, which means they emit less fumes than the high-polluting, oil-based paints and solvents.

For several decades, scientists have tried to unravel why allergies and asthma have skyrocketed among children throughout the developed world since the 1970s.

Experts suspect that exposure to some environmental factors in the womb or early in life might trigger the disorders. The findings of the new study add to the many theories that have evolved, including ones about other indoor air pollutants, diesel exhaust, viruses and cockroach allergens.

Michael Laiosa, an assistant professor at the School of Public Health at University of Wisconsin, Milwaukee, who studies children’s allergies and immune disorders, called it “a very interesting article and well-conducted study.’’

If these findings are confirmed by other studies, “it may be another piece of the puzzle as to why atopic diseases like allergy and asthma are on the rise, particularly in kids,” said isa, who was not involved in the research.

“It also is concerning given how ubiquitous these compounds are, particularly at low levels like those found in this study,” he said.

The research involved 198 children in Varmland, Sweden, between the ages of 1 and 5, who had asthma or at least two symptoms or wheezing or rhinitis without a cold or eczema in the previous year, as well as 202 children with no symptoms.

For children with rhinitis – or nasal allergies – the average PGE concentration in their bedrooms was twice as high as the concentration found in rooms of the children with no symptoms. The higher the dose, the more likely the children were to suffer from rhinitis, asthma, or eczema, even when concentrations were low.

Children in bedrooms with the highest concentrations were 4.2 times more likely to have rhinitis, twice as likely to have asthma and 2.5 times more likely to have eczema, compared with children with the lowest concentrations in their rooms.

High concentrations of the chemicals also doubled their likelihood of testing positive for immunoglobulin E, an antibody that develops when people are exposed to something that inflames their airways. None of the other VOCs led to similar associations.

The researchers did not identify the sources of the PGEs in the bedrooms. But children living in a house where at least one room was painted right before or after their birth had 63 percent more PGEs in their room than those whose houses had not been repainted. “Thus, repainting might have provided a sustained exposure since the gestational period or shortly following the birth,” the study said.

The airborne compounds can remain inside homes for months, perhaps even years.

“Overall, the question of long-term airway injury from the glycol ethers and other organic solvent exposure requires clarification,” wrote the scientists.

How the glycol compounds might trigger allergies and asthma “is not well understood,” the authors said, but they added that “it has been known for more than three decades” that inhalation of propylene glycol methyl ether irritates nasal passages of people and lab rats.

Asthma, eczema and allergies are inflammatory, immune system disorders, so it is possible that the compounds disrupt a baby’s or child’s immune system development. Some of the compounds already are known to alter hormones.

“Several glycol ether compounds join a growing list of VOCs that are suggested to contribute to allergic diseases in humans,” the study says. “While several PGEs are well-known endocrine disruptors, very little is known whether and how they influence developing immune systems.”

Laiosa added that “one of the most interesting aspects for me is that our understanding of how VOCs in general, and PGEs specifically, affect the immune system, is quite limited.”

Previous studies of house painters and some adult volunteers exposed to some PGEs have found higher incidence of nose and throat irritation, wheezing and shortness of breath. But the levels found in the children’s bedrooms are “more than 400-fold lower than exposure ranges reported in occupational and experimental settings,” according to the report.

“Several lines of evidence support that our findings are not due to a chance or a bias,” the authors reported. For instance, the increase in allergies, eczema and asthma were observed for every rise in exposure, from the lowest-exposed children to the highest-exposed. In addition, it wasn’t driven by any single compound.

“This suggests that multiple compounds, rather than a single one, contribute to the observed risks,” the report says.

A compound called 1-methoxy-2-propanol was the most prevalent glycol ether in the children’s rooms. But because multiple types of PGEs were found in the children’s homes, “we currently cannot distinguish the risks of the individual compounds,” the authors said.

In their analysis, the researchers accounted for other factors that might raise the children’s risk, including secondhand smoke, allergies of parents, cleaning with chemical agents, age of the homes, pet allergens and exposure to other indoor chemicals called phthalates.

Laiosa said that testing for VOCs is tricky, but the researchers “did an admirable job” of identifying the limitations of their study and ensuring the testing methods were reliable.

The levels found in the bedrooms were strikingly similar to those found in previous studies of homes in other Scandinavian countries.

That finding “is a strength of this work,” Laiosa said. “In other words, I don't think anyone can question the validity that these PGEs are present in the children's bedrooms, even at such low levels. “

Many volatile organic compounds have been regulated in recent years to clean up smog. The petroleum-based compounds, found in car exhaust as well as consumer products, react in sunlight with nitrogen oxides to form ozone, the main ingredient of smog.

Carl-Gustaf Bornehag , a professor of public health science at Sweden’s Kalstad University, and John Spengler, an environmental health professor at the Harvard School of Public Health, conceived of and designed the experiments, while the lead author was Harvard’s Hyunok Choi.

Via : scientificamerican

Friday, October 22, 2010

Study says Low-dose Aspirin Safe Way to Reduce Colon Cancer Risk

A recent study showed that taking lower dose of aspirin is a safer way to reduce the risk of colon cancer.

British researchers found out that taking a lower dose of aspirin can help reduce number of cases of colon cancers and its cancer death rates.

Colon cancer is the second to the leading cancer form in developed countries, and the findings bring light to their research that aspirin can help a person in preventing the occurrenceof colon cancer.

The findings been published in the Lancet Medical Journal, however the findings are unlikely to settle due to the controversies about aspirin.

In previous studies, it shows that people who take high levels and doses of aspirin can be very effective in preventing the developmentof colon cancer to a person.

However, consumption of this medicine can be very hazardous to most people; it oftentimes caused deadly and serious bleeding in a person’s intestines and stomach.

Another study regarding to a related painkiller medicine, ibuprofen also help reduce the cancer rates of colon cancer, for people who take the medication over a long period of time.

Lead author of the study, Peter Rothwell, from John Radcliffe Hospital in Oxford, together with his team, conducted four large studies of more than 14,000 people. Half of their subjects take low-dose of aspirin intended for treating heart disease.

Eighteen years later, only 2.8 percent of those volunteers developed and acquired colorectal cancer. They have found out that aspirin effectively reduce the risk of this illness by 24 percent, and at the same time it also lowered the risk of a person to die from this kind of disease by almost 35 percent.

These findings can help people who cannot afford expensive diagnosis and treatments for colon cancer, to get an affordable medication to prevent colorectal cancer in the future.

Via : seedol

Salix gets global license for Photocure's colon cancer diagnostic test

Norwegian specialty pharmaceutical company Photocure (OSE: PHO) said Wednesday it has signed a global agreement with Salix Pharmaceuticals (NASDAQ:SLXP) for the development and commercialization of Lumacan, a diagnostic test for colon cancer.

Colon cancer is traditionally diagnosed through colonoscopies with white light, which is increasingly known for its limitations in detecting cancer.

Lumacan is being developed to increase the detection rate for precancerous polyps and colon cancer through fluorescence diagnosis. In the US, it is estimated that approximately 14 million colonoscopies are done annually for diagnosis of colon cancer.

According to Photocure, earlier studies have shown a near 40% increased detection rate when Lumacan-colonoscopy diagnostic was used and the test is currently in Phase I/II trials.

Under the terms of the agreement, Salix will obtain an exclusive worldwide license to Lumacan, excluding the Nordic region, where Photocure has retained its rights.

In exchange for this, Photocure will receive a signing fee of US$4 million and is entitled to receive additional milestone payments totalling up to US$126.5 million, if certain conditions are satisfied.

In addition to the milestones, Salix will pay Photocure tiered double digit royalties on net sales and pay a percentage of all Salix sublicense revenue worldwide, outside of the US.

As a result of the deal, Salix will control and cover development, registration and commercialization costs for Lumacan globally, with Photocure covering certain costs of formulation development up to US$3 million, it said.

Aside for the indication of colorectal cancer, Salix will as well have the right to explore and develop products for additional indications involving the diagnosis of gastrointestinal dysplasia and cancer. Payments for products in respect to these indications will be negotiated in the future, said the companies.

"We believe Lumacan is truly an innovative and groundbreaking diagnostic which should complement our portfolio of gastrointestinal offerings. Lumacan's efficacy results thus far have been promising and show great potential if approved for marketing by the FDA," said CEO of Salix Carolyn Logan.

Salix said that Lumacan will target high risk screening patients and diagnostic patients in follow-up of colon cancer.

Via : proactiveinvestors